EOM Pharmaceuticals Holdings, Inc. (IMUC)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 11:08AM EDT
| Previous Close | 0.1979 |
| Open | 0.1650 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 3000 |
| Day's Range | 0.1979 - 0.1979 |
| 52 Week Range | 0.1100 - 0.4000 |
| Volume | |
| Avg. Volume | 3,216 |
| Market Cap | 22.416M |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | 0.02 |
| EPS (TTM) | 10.9900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireEOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key pro-inflammatory and anti-inflammatory cytokines with potential therapeutic utility in treating a variety of acute and chronic inflammatory conditions.
© 2024 Yahoo. All rights reserved.